atenolol has been researched along with Epilepsy in 4 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| ", ip) indicate that the liver is the primary site of biotransformation of the compound, suggesting that both 22a and its metabolite(s) are active, compensating probably low bioavailability of the parent molecule." | 1.43 | Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. ( Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waszkielewicz, AM | 1 |
| Gunia-Krzyżak, A | 1 |
| Powroźnik, B | 1 |
| Słoczyńska, K | 1 |
| Pękala, E | 1 |
| Walczak, M | 1 |
| Bednarski, M | 1 |
| Żesławska, E | 1 |
| Nitek, W | 1 |
| Marona, H | 1 |
| Eirís-Puñal, J | 1 |
| Rodríguez-Núñez, A | 1 |
| Fernández-Martínez, N | 1 |
| Fuster, M | 1 |
| Castro-Gago, M | 1 |
| Martinón, JM | 1 |
| Russell, D | 1 |
| Veger, T | 1 |
| Bunaes, UB | 1 |
| Efskind, PS | 1 |
| Oppenheimer, SM | 1 |
| Cechetto, DF | 1 |
1 trial available for atenolol and Epilepsy
| Article | Year |
|---|---|
Usefulness of the head-upright tilt test for distinguishing syncope and epilepsy in children.
Topics: Adolescent; Age Factors; Anticonvulsants; Atenolol; Child; Diagnosis, Differential; Diagnostic Error | 2001 |
3 other studies available for atenolol and Epilepsy
| Article | Year |
|---|---|
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Dru | 2016 |
Epileptic seizures precipitated by atenolol.
Topics: Adult; Atenolol; Epilepsy; Humans; Male; Propanolamines | 1979 |
Cardiac chronotropic organization of the rat insular cortex.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Atropine; Cerebral Cortex; Cerebrovascular Disorders; Elect | 1990 |